Have Sight Sciences Insiders Been Selling Stock?

Investors may wish to note that the Co-Founder of Sight Sciences, Inc., Paul Badawi, recently netted US$73k from selling stock, receiving an average price of US$2.92. On the bright side, that's just a small sale and only reduced their holding by 0.4%.

Check out our latest analysis for Sight Sciences

Sight Sciences Insider Transactions Over The Last Year

The Independent Chairman, Staffan Encrantz, made the biggest insider sale in the last 12 months. That single transaction was for US$2.1m worth of shares at a price of US$3.73 each. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. It's of some comfort that this sale was conducted at a price well above the current share price, which is US$2.96. So it may not shed much light on insider confidence at current levels.

In total, Sight Sciences insiders sold more than they bought over the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

For those who like to find hidden gems this free list of small cap companies with recent insider purchasing, could be just the ticket.

Does Sight Sciences Boast High Insider Ownership?

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. I reckon it's a good sign if insiders own a significant number of shares in the company. It appears that Sight Sciences insiders own 19% of the company, worth about US$28m. While this is a strong but not outstanding level of insider ownership, it's enough to indicate some alignment between management and smaller shareholders.

What Might The Insider Transactions At Sight Sciences Tell Us?

Unfortunately, there has been more insider selling of Sight Sciences stock, than buying, in the last three months. Zooming out, the longer term picture doesn't give us much comfort. Insider ownership isn't particularly high, so this analysis makes us cautious about the company. We're in no rush to buy! In addition to knowing about insider transactions going on, it's beneficial to identify the risks facing Sight Sciences. At Simply Wall St, we found 2 warning signs for Sight Sciences that deserve your attention before buying any shares.

But note: Sight Sciences may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.